Granulocyte-monocyte Apheresis in Ulcerative Colitis

Valduce Hospital

Status: Completed

Conditions: Ulcerative Colitis

Treatments: Device: apheresis

Study type: Interventional

Funder types: Other

Identifiers

NCT03189888

5/2012

Details and patient eligibility

About

BACKGROUND: Granulocyte-monocyte apheresis has been proposed for the treatment of ulcerative colitis, although is limited by costs and variability of results.

Enrollment: 33 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• moderate UC with steroid-dependence and azathioprine intolerance or resistance

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

33 participants in 1 patient group

apheresis

Other group

Description:

leukapheresis in ulcerative colitis

Treatment:

Device: apheresis